Published in Eff Clin Pract on September 05, 2001
A randomized controlled trial to increase cancer screening among attendees of community health centers. Ann Fam Med (2004) 1.37
The uptake and effect of a mailed multi-modal colon cancer screening intervention: a pilot controlled trial. Implement Sci (2008) 1.36
Impact of mailed and automated telephone reminders on receipt of repeat mammograms: a randomized controlled trial. Am J Prev Med (2009) 1.08
Evaluating a tailored intervention to increase screening mammography in an urban area. J Natl Med Assoc (2005) 1.05
Self-report and primary care medical record documentation of mammography and Pap smear utilization among low-income women. J Natl Med Assoc (2004) 1.05
Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. Clin Gastroenterol Hepatol (2007) 0.96
Cost effectiveness of a telephone intervention to promote dilated fundus examination in adults with diabetes mellitus. Clin Ophthalmol (2008) 0.92
Enhancing the use of mammography: effectiveness and cost. Eff Clin Pract (2001) 0.78
A comparison of physical therapy, chiropractic manipulation, and provision of an educational booklet for the treatment of patients with low back pain. N Engl J Med (1998) 7.20
Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med (1994) 7.17
Multiple essential functions of neuregulin in development. Nature (1995) 5.66
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J Cell Biol (2001) 3.84
Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst (1995) 3.81
Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation (2001) 3.33
Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol (1993) 3.32
Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity (1996) 2.96
Ultrafast bond softening in bismuth: mapping a solid's interatomic potential with X-rays. Science (2007) 2.84
Back pain in primary care. Outcomes at 1 year. Spine (Phila Pa 1976) (1993) 2.71
Randomized trial comparing traditional Chinese medical acupuncture, therapeutic massage, and self-care education for chronic low back pain. Arch Intern Med (2001) 2.67
Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry (1995) 2.66
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost (2006) 2.56
Susceptibility locus for Alzheimer's disease on chromosome 10. Science (2000) 2.49
Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst (1999) 2.49
Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA (2001) 2.45
CYP98A3 from Arabidopsis thaliana is a 3'-hydroxylase of phenolic esters, a missing link in the phenylpropanoid pathway. J Biol Chem (2001) 2.32
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost (1992) 2.31
Common-sense models of illness: the example of hypertension. Health Psychol (1985) 2.26
Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry (1995) 2.21
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet (2005) 2.13
Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation (1999) 2.09
Predicting poor outcomes for back pain seen in primary care using patients' own criteria. Spine (Phila Pa 1976) (1996) 1.99
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol (1995) 1.91
Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood (1996) 1.89
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice. J Thromb Haemost (2005) 1.88
Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens (2004) 1.86
The effect of a shared decisionmaking program on rates of surgery for benign prostatic hyperplasia. Pilot results. Med Care (1995) 1.86
Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J Biol Chem (1984) 1.83
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost (2008) 1.81
Congenital upper eyelid eversion complicated by corneal perforation. Br J Ophthalmol (2005) 1.73
Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood (2001) 1.69
Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest (1976) 1.67
Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst (1997) 1.66
Evidence that the Ya and Yc subunits of glutathione transferase B (ligandin) are the products of separate genes. Eur J Biochem (1982) 1.65
A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother (1997) 1.64
Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost (2000) 1.62
Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest (1992) 1.62
Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost (2001) 1.60
Structure-function relationship of human von Willebrand factor. Blood (1987) 1.60
Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost (1995) 1.58
Thrombotic risk factors in pulmonary hypertension. Eur Respir J (2000) 1.54
Assessing mammographers' accuracy. A comparison of clinical and test performance. J Clin Epidemiol (2000) 1.51
Patterns of antidepressant use in community practice. Gen Hosp Psychiatry (1993) 1.51
International survey of patients with von Willebrand disease and angiodysplasia. Thromb Haemost (1993) 1.51
Agriculture. Transforming U.S. agriculture. Science (2011) 1.51
Academic stress, power motivation, and decrease in secretion rate of salivary secretory immunoglobulin A. Lancet (1983) 1.49
Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J Immunol (1998) 1.49
Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost (2000) 1.48
Ocular trauma in an urban population. Review of 1132 cases. Ophthalmology (1990) 1.42
Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei. J Clin Microbiol (1998) 1.42
A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr (2007) 1.38
[Nononcologic abdominal surgery in the elderly]. Chirurg (2005) 1.38
Long-term follow-up of Stargardt's disease and fundus flavimaculatus. Ophthalmology (1998) 1.37
Use of exogenous hormones and risk of temporomandibular disorder pain. Pain (1997) 1.35
Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation. Br J Haematol (1974) 1.29
Cloning and developmental expression of the murine neurofilament gene family. Brain Res (1986) 1.28
The zebrafish forkhead transcription factor FoxH1/Fast1 is a modulator of nodal signaling required for organizer formation. Curr Biol (2000) 1.27
Effect of variations in operational definitions on performance estimates for screening mammography. Acad Radiol (2000) 1.27
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med (1982) 1.26
Pitfalls of patient education. Limited success of a program for back pain in primary care. Spine (Phila Pa 1976) (1996) 1.25
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thromb Haemost (2001) 1.25
Variation in mammographic breast density by race. Ann Epidemiol (2001) 1.24
Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep (1975) 1.24
Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene. Eur J Hum Genet (1993) 1.24
Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease. J Lab Clin Med (1980) 1.19
Eccentric localization of von Willebrand factor in an internal structure of platelet alpha-granule resembling that of Weibel-Palade bodies. Blood (1985) 1.18
Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies. Vet Clin Pathol (2005) 1.17
Report from a forum on US heart allocation policy. Am J Transplant (2015) 1.17
Effects of practice style in managing back pain. Ann Intern Med (1994) 1.16
Behavioral phenotyping of mice lacking the K ATP channel subunit Kir6.2. Physiol Behav (2006) 1.15
Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components. EMBO J (2001) 1.14
Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor. Br J Haematol (1980) 1.14
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost (2006) 1.14
Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF. Thromb Haemost (1999) 1.14
Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol (1996) 1.13
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study. J Thromb Haemost (2009) 1.13
Clinical, serologic, and epidemiologic characteristics of ocular toxocariasis. Am J Trop Med Hyg (1979) 1.11
Characteristics of Actinobacillus actinomycetemcomitans invasion of and adhesion to cultured epithelial cells. Adv Dent Res (1995) 1.11
Medication use for low back pain in primary care. Spine (Phila Pa 1976) (1998) 1.10
Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). J Thromb Haemost (2004) 1.10
Standard nomenclature for factor VIII and von Willebrand factor: a recommendation by the International Committee on Thrombosis and Haemostasis. Thromb Haemost (1985) 1.10
Ocular complications of dental local anaesthesia. SADJ (1998) 1.10
Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis (1987) 1.09
Vg1 RBP intracellular distribution and evolutionarily conserved expression at multiple stages during development. Mech Dev (1999) 1.09
Examination of the patient with a knee dislocation. The case for selective arteriography. Arch Surg (1992) 1.07
von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system. Thromb Haemost (2000) 1.07
Purification and partial amino acid sequence of the chloroplast cytochrome b-559. J Biol Chem (1984) 1.07
Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene. Oncogene (1997) 1.07
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med (1983) 1.06
Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost (2000) 1.06
Thrombotic thrombocytopenic purpura and its diagnosis. J Thromb Haemost (2005) 1.05
Orbital fractures in children. Arch Otolaryngol Head Neck Surg (1995) 1.04
Multiple founder haplotypes of mitochondrial DNA in Amerindians revealed by RFLP and sequencing. Ann Hum Genet (1996) 1.04
Ocular anomalies simulating double optic discs. Can J Ophthalmol (1981) 1.03
Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol (1996) 1.03
Activation and substrate specificity of the human protein kinase C alpha and zeta isoenzymes. Eur J Biochem (1993) 1.03
Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood (1996) 1.02